Friday, May 29, 2009

Sayonara, SiCortex

I was sad to see the news this week that Maynard-based SiCortex is shutting down and selling of its assets after investors decided to turn off the tap. The ambitious maker of high-performance computers had raised $42 million, and CEO Chris Stone told me they'd shipped 60 of the machines in 2008 when we spoke late that year. (More coverage from Xconomy, GigaOm, and HPCwire.)

Some famous last words from my December 2008 chat with Stone:

    "Do I worry about raising money in this environment? Sure," Stone says. "But we're generating revenue, and the customers want to buy more."


The shut-down is bad news for local VC firms Flagship Ventures, Prism VentureWorks, and Polaris Venture Partners. (Bob Metcalfe was the Polaris partner who served on SiCortex's board; another of his portfolio companies, Greenfuel, also shut down in May.)

Ex-employee Jeff Darcy has an analysis of what went wrong on his blog:

    The only failure that mattered was not technical, nor in any area of customer-oriented execution: it was purely a matter of finance and timing. There is every reason to believe that our next system based on our next chip was going to be awesome, pushing our flagship system well into the Top 500 even before we talk about linking them together, and development was well along. Unfortunately, such development is not cheap and that put us in a high-burn-rate phase right when the economy turned sour and capital became very scarce. That’s like a “perfect storm” combination of circumstances. Maybe there are some things we could have done differently, but “coulda woulda shoulda” is a dangerous game. For example, some might say we should have cut costs sooner, even if it meant delaying the arrival of that next system, and tried to “weather the storm” until a better funding environment came around. Maybe. Or maybe, under other equally-likely conditions, that would have led to a far more ignominious failure as our competitors took the same extra time to adopt our approaches and use superior resources to leave us behind technologically. No thanks. I’m not in any mood to second-guess the people who made those decisions. I’d rather believe, and I think I’m justified in believing, that we played a good game and can walk off the field with our heads held high even though the score wasn’t in our favor.


Here's some video I shot at SiCortex's HQ in December 2008:


Labels: , , , , , ,

Sunday, September 14, 2008

Career Opps in Cleantech, and the Most Significant Cleantech VC Firms in Boston

Today's Globe column deals with people moving into cleantech from other fields. From the opening:

    In the late 1990s, everyone wanted to be part of the Internet revolution. Now, there's a similar level of enthusiasm building around companies tackling the world's energy challenges. And many people from the biotech, software, and hardware fields are seeking out - and finding - opportunities to make a career switch.


In the video, Peter Rothstein and Jim Matheson of Flagship Ventures talk about how to navigate that switch:



While working on the piece, I asked everyone I spoke with who the most significant cleantech VC firms in the Boston area are. Here's the list (in alphabetical order, not in order of significance), and who the point person is where there's one primary energy-oriented partner.

Labels: , , , , ,

Tuesday, October 2, 2007

Adobe, Google Grab Local Start-Ups

Two small Boston-area start-ups have been adopted by California parents: Adobe and Google.

Zingku runs a mobile social networking service; originally known as Bloobird Studio and funded by Flagship Ventures, the company's founders include Martin Fahey (formerly CEO at WebHire), Mussie Shore, and Sami Shalabi. (All three are Lotus Development Corp. alums.) Google acquired Zingku late last month, but didn't announce the purchase price.

From the PC World story:

    Zingku aims to make it easier for people to share photos, send invitations or conduct polls among friends via mobile phone. It also provides a way for businesses to send "mobile flyers" to customers advertising products and services.

    Zingku was started in 2005 and the service has been in testing with a limited number of users in the U.S. New account sign-ups have been frozen following Google's acquisition, according to Zingku's Web site. Existing accounts will be transferred to Google unless they are cancelled by Oct. 4.

    Detailed terms of the acquisition weren't provided and Google didn't return calls seeking comment. The company has confirmed that it bought "certain assets and technology of Zingku," according to the Google Operating System blog, which first reported the deal, and is not owned by Google.


And Waltham-based Virtual Ubiquity has been acquired by Adobe, also for an undisclosed amount. Virtual Ubiquity makes the Web-based word processor Buzzword. The company received some funding from Adobe's venture capital arm last year. This sets Adobe up to compete with Google in the battle for users of Web-based writing tools. (Tim O'Reilly says that Buzzword is superior to Google Docs.) Virtual Ubiquity's CEO was another Lotus alum, Rick Treitman. Here's the announcement from the company's blog.

Labels: , , , , , ,

Monday, September 24, 2007

Instead of Going Public, Adnexus Shacks Up with Bristol-Myers Squibb

Bristol-Meyers Squibb is paying $430 million in cash for Waltham-based Adnexus Therapeutics, which filed an S-1 statement just last month. The company planned to raise $86 million in an IPO, on top of $76 million it had already raised in VC money.

We included them earlier this year on our list of the ten most-promising New England life sciences start-ups, in the second edition of The Convergence Guide. (The list was compiled by Steven Dickman of CBT Advisors.)

From the AP report:

    The companies said the acquisition of Adnexus will help advance Bristol-Myers's role in biologics and includes an early stage trial for cancer treatment candidate Angiocept. Angiocept is designed to be a so-called anti-angiogenic drug, or one that tries to stop cancerous tumors from developing new blood vessels.

    The deal "is an important step in accelerating the strategic transformation of our pharmaceutical business to a biopharma business model," said Bristol-Myers Squibb Chief Executive Jim Cornelius, in a statement.


Among the local VC firms that backed Adnexus are Polaris Venture Partners, Atlas Venture, and Flagship Ventures. The company did a Series C round of $15.5 million just before filing for its IPO.

Update: Tuesday's Globe has the full story.

Labels: , , , , , , , , ,

Wednesday, August 15, 2007

Top Innovators Under 35: From Technology Review

Technology Review, MIT's alumni newsletter, put out its annual list of the most interesting innovators under 35 today.

Who's on the list from New England?

Labels: , , , , , , , , ,